title: Differential effects of selective neurokinin agonists on phasic and tonic activity in rat ileal longitudinal muscle.
abstract: To test the hypothesis that different neurokinin receptors might be involved in the generation of either phasic or tonic muscular activity, selective ligands for the 6 neurokinin-1-receptor, [Sar9, Met(O2)]-SP, the neurokinin-2-receptor, [Nle10]-NKA4-10, and the neurokinin-3 receptor, [beta Asp4,MePhe7]-NKB4-10, were used to evaluate the excitatory effects of these agonists in the longitudinal rat ileal muscle in vitro. The excitatory effect was analyzed as total response (area under the curve) and as tonic or phasic (area under or within the peaks) activity. Substance P (SP, relative amount of phasic activity in comparison to total activity: 3 x 10(-8) M 87%, 3 x 10(-6) M 30%) and the neurokinin-2-receptor selective agonist [Nle10]-NKA4-10 (N-NKA: 3 x 10(-8) M 67%, 3 x 10(-6) M 59%) caused both tonic and phasic responses, with the percentage of phasic responses decreasing at higher concentrations. The neurokinin-1-receptor selective agonist [beta Ala4, Sar9, Met(O2)]-SP4-11 caused a predominantly tonic response with only a small phasic component (10(-8) M 27.1% 10(-6) M 13.8%). The selective neurokinin-3 receptor agonist [beta Asp4, MePhe7]-NKB4-10 caused a predominantly phasic motor response (SM-SP: 3 x 10(-8) M 98%, 3 x 10(-6) M 87%). Tetrodotoxin (TTX 10(-6) M), omega-conotoxin (CTX 10(-7) M) and atropine (10(-6) M) had no significant influence on the contractile responses to all four peptides, indicating a direct action on the smooth muscle cell.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine II, Technical University of Munich, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Willis
authors.forename: H D
authors.initials: HD
authors.lastname: Allescher
authors.forename: V
authors.initials: V
authors.lastname: Schusdziarra
authors.forename: D
authors.initials: D
authors.lastname: Regoli
authors.forename: G
authors.initials: G
authors.lastname: Drapeau
authors.forename: M
authors.initials: M
authors.lastname: Classen
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010455:Peptides / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018040:Receptors, Neurokinin-1 / Q000187:drug effects*; D018041:Receptors, Neurokinin-2 / Q000187:drug effects*; D018042:Receptors, Neurokinin-3 / Q000187:drug effects*; D013779:Tetrodotoxin / Q000494:pharmacology; D020960:omega-Conotoxins
chemical_list: D002121:Calcium Channel Blockers; D010455:Peptides; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D018042:Receptors, Neurokinin-3; D020960:omega-Conotoxins; C053423:Conus magus toxin; D013779:Tetrodotoxin; D001285:Atropine; D002118:Calcium